Harvard Biosciences and a team of international surgeons and scientists have successfully collaborated to create and implant a bioartificial trachea. The trachea was created by growing stem cells onto a spongy scaffold with appropriate physical properties. The growth phase of the process took between 10 to 12 days and included chemical or physical triggers to … Continue reading Biotechnology: Artificial Trachea Grown From Stem Cells And Implanted
Tag: Biotechnology Product Development
Monsanto Surges Ahead of the Pack in Part or Whole Animal Biotech Related Patents
Monsanto Corporation has been aggressively patenting in the Whole Animal or Part category. It can only be assumed that this is part of an overall strategy to control the market worldwide in genetically modified food products. Starting from the middle of the pack in 2006 Monsanto had increased its patents in this area ten fold … Continue reading Monsanto Surges Ahead of the Pack in Part or Whole Animal Biotech Related Patents
Top Ten Companies Patenting Multicell Organisms ( Life ) or Parts
So why do we want to know who is patenting multicellular organisms or their parts? That will depend on whether the reader is interested in getting into a company that is actively considering commercialization possibilities in this particular area or a Research/Development Engineer trying to determine who is actively patenting for competitive intelligence purposes. Agricultural … Continue reading Top Ten Companies Patenting Multicell Organisms ( Life ) or Parts
Top Ten Schools Patenting Multicell Organisms or Parts
So why do we want to know who is patenting multicellular organisms or their parts? That will depend on whether the reader is interested in getting into a school that is actively considering commercialization possibilities in this particular area or a Research/Development Engineer trying to determine who in the academic world is actively patenting. Agricultural … Continue reading Top Ten Schools Patenting Multicell Organisms or Parts
Regulatory: FDA Is Equipping The Park Doctrine
The FDA has become increasingly active in its determination to discipline apparently unrepentant pharmaceutical firms. Now its getting personal, again. After years of neglect the usefulness of the Park Doctrine has been rediscovered by the FDA. The evidence needed to apply it to a "responsible corporate official" appears to be nil. The definition of a … Continue reading Regulatory: FDA Is Equipping The Park Doctrine
